AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Policy & practice.(Practice Trends)

OB GYN News

| June 01, 2004 | Schneider, Mary Ellen | COPYRIGHT 2004 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

ACADEMIC SALARIES High-demand specialists such as ob.gyns. may be starting to make more money in academic settings to better compete with the private sector, according to a new report from the Medical Group Management Association (MGMA). Median total compensation for ob.gyns. in an academic setting increased 9.4% between 2002 and 2003 to $181,613 annually. Overall, the median total compensation for specialist physicians in academic medicine rose 3.2%. "Increases in physician compensation for academic medical practices tend to mirror high-demand specialties," said Kathryn A. Mahaffey, chair of the MGMA survey advisory committee. "For academic practices to remain competitive and attract adequate levels of specialists, some medical schools may have to raise compensation to more closely match our private-sector counterparts."

TOP 10 RANKING The United States ranked 10th on the Save the Children's "Mother's Index," which compares the well-being of mothers and children in 119 countries. The index compares countries based on the lifetime risk of maternal mortality, use of modern contraception, births attended by trained personnel, prevalence of anemia among pregnant women, female literacy, and participation of women in national government. The index compares the well-being of children, using as benchmarks infant mortality, nutritional status, primary school enrollment, and access to safe water. Sweden, Denmark, and Finland topped the rankings this year. Mali. Burkina Faso, and Niger were at the bottom.

STEM CELL EXPANSION More than 200 members of Congress from both parties are calling on President Bush to expand the administration's policy on research using embryonic stem cells. In August 2001. President Bush established a policy allowing the use of federal funds for research on embryonic stem cell lines that existed as of Aug. 9, 2001, and which met certain criteria. There are 19 embryonic stem cell lines available to researchers under the policy, according to the ...

Related articles from newspapers, magazines, journals, and more
Athersys and Angiotech announce authorization of Phase I intramyocardial stem...
Newspaper article from: BIOTECH Patent News December 1, 2007 700+ words
...received authorization from the United States Food and Drug Administration to...MultiStem, Athersys' non-embryonic stem cell platform technology, for use in...approvals of our 5-FU CVC in the United States and our Vascular Wrap product in...
Stem cell policies in the United States and in Germany: between bioethics and...
Magazine article from: Policy Studies Journal Gottweis, Herbert December 22, 2002 700+ words
...human embryonic stem cell research in the United States and in Germany...human embryonic stem cell research have...place in the United States, where a growing...between the United States and Germany...human embryonic stem cell research and...
Vitro Receives Adult Stem Cell Patent from the United States Patent and...
Press release article from: Business Wire June 9, 2009 700+ words
...it has been awarded United States Patent number 7,527...diabetes. Our issued United States patents now include...pending technology for stem cell therapy of cancer...launched, "Tools for Stem Cell and Drug Development...
Vitro Receives Notice of Allowance for Adult Stem Cell Patent from the United...
Press release article from: Business Wire January 28, 2009 700+ words
...notification from the United States Patent Office (USPTO...impending issuance of a new United States patent. Dr. Jim Musick...Allowance for our adult stem cell patent from the USPTO...the effectiveness of stem cell therapy in the treatment...
Embryonic stem cell research: will President Bush's limitation on federal...
Magazine article from: Houston Journal of International Law Stevens, Denise March 22, 2003 700+ words
...huge potential of stem cell research. (16...laws regulating stem cell research, both in the United States and internationally...funding of embryonic stem cell research. This...conclusion is that the United States will be seriously...
RhenoGene received $2 million from NIST-ATP to develop novel stem cell...
Newspaper article from: Transplant News October 30, 2004 700+ words
...The company says the grant will be used to create neural stem cell therapies to restore lost vision in patients with retinal and...the award will also have broad application to advancing other stem cell therapies for chronic and incurable conditions through the...
Stem-Cell Ethics Debate Differs in United States, Sweden.
Newspaper article from: Knight Ridder/Tribune Business News March 30, 2003 700+ words
...controversy: embryonic stem cell research. "It...While both the United States and Sweden are world...guidelines for embryonic stem cell research. As in the United States, the embryos would...can be used on new stem cell lines. Critics...
The Dangers of Delay : Restrictions on stem-cell research in the United States...
Magazine article from: Newsweek International Fischbach, Gerald D. January 13, 2003 700+ words
...clear from experiments with animals that stem-cell therapies can reduce human suffering...The cost in dollars of delaying new stem-cell research is difficult to estimate. It...science community could extend far beyond stem-cell research. Many therapies have emerged...
For more facts and information, see all results

Source: HighBeam Research, Policy & practice.(Practice Trends)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA